Reliance Biosciences Incorporated
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
Providing the latest molecular diagnostic technology for early-stage Alzheimer's disease through the detection of protein biomarkers present on exosomes in the blood.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2019
Unified Business No.
85092629
Status
Active
Number of Employees
0
Total Paid-in
Capital
31,299,319 (NT$)
Location of Company
Taiwan
, New Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Reliance Biosciences Incorporated provides molecular in vitro diagnostics (IVD) for the management of Alzheimer's and cancer. Using 10 microliters of plasma, it detects protein expression on exosomes to provide highly sensitive, real-time disease information. Our medical team is composed of experts from National Taiwan University Hospital, Harvard University, and Massachusetts General Hospital (Boston), while our technical team comes from National Taiwan University, possessing expertise in microfabrication, antibody science, detection technology, electrochemistry, materials, and regulatory affairs.
(The content above was translated by AI.)
(The content above was translated by AI.)
